<DOC>
	<DOCNO>NCT01233219</DOCNO>
	<brief_summary>Identification genetic polymorphism could correlate either good clinical response major predisposition patient develop tolerance and/or side effect treatment morphine .</brief_summary>
	<brief_title>Association Between Clinical Effect Continuous Morphine Administration After Surgery Pharmacogenetics</brief_title>
	<detailed_description>Valuation rescue dos necessary maintain NRS &lt; 4 first 24 hour post-surgery two group patient , A e B . Group A : homozygous patient frequent allele polymorphism A118G OPRM1 gene ( 80 % ) ; group B : homozygous heterozygous patient less frequent allele ( 20 % ) .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<criteria>Inclusion criterion : Males females 18 year , 75 year , schedule postoperative pain control continuous morphine administration HIV negative Classification American Society Anesthesiologists ( ASA ) I : without systemic disease Classification ASA II III ( mild systemic disease severe systemic disease limit activity without invalidity ) . Undergoing abdominal urologic major surgery ( neither urgent emergency surgery ) Signed informed consent Exclusion criterion : Usual assumption analgesic opioids Cognitive alteration mental retardation Severe hepatic/renal insufficiency ( cholinesterase &lt; 3000 mU/ml , total bilirubinaemia &lt; 2 mg/dl creatininaemia &lt; 1.2 mg/dl ) Inpatients intensive therapy , either sedation and/or mechanic ventilation . Allergies morphine derivates</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>systemic morphine analgesia</keyword>
	<keyword>pharmacogenetics</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>